Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
- FTSE closes down 23.22 at 6,689.45 - China registers surprise trade deficit - Japan GDP revised lower - BCC increases growth forecast techMARK 2,845.16 -0.52% FTSE 100 6,689.45 -0.35% FTSE 250 16,451.20 -0.65% It was a negative finish for the FTSE today, dragged lower by miners on the back of po
Read moreRolls Royce was in the top spot today after a host of analysts lifted their target prices following the engine group's move last week to buy-out Daimler in their 50-50 joint venture, Rolls-Royce Power Systems (RRPS). After the close of trade on Friday, Rolls-Royce said that it is to buy the remain
Read more
LONDON (Alliance News) - London's capital markets continued a resurgence Monday as two more companies announced that they intend to list, another started trading, and AIM-listed Fyffes PLC said it would be acquired by Chiquita Brands International Inc of the US in a deal that
Read moreLONDON (Alliance News) - The following is a summary of top news stories Monday.
----------
COMPANIES
----------
Chiquita Brands International Inc and Fyffes PLC said they have reached a deal whereby Chiquita will acquire Fyffes to create th
LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning and Friday afternoon:
----------
FTSE 100
----------
DEUTSCHE BANK CUTS ROLLS-ROYCE PRICE TARGET TO 860 (1090) PENCE - 'SELL'
----------
MERRILL LYNCH
LONDON (Alliance News) - Shares have opened higher Monday despite a weak lead from Asia.
M&A and share placings have grabbed attention at the open.
Chiquita Brands International Inc and Fyffes PLC said they will merge to create the world's largest ba
GlaxoSmithKline (GSK) has increased its stake in its pharmaceuticals subsidiary in India from 50.7 to 75 per cent following an open offer. The transaction was valued at approximately £625m. The group said the move would increase its exposure to a "strategically important market". "It is a sign
Read moreLONDON (Alliance News) - Drugs giant GlaxoSmithKline PLC Monday launched the GBP629 million open offer to increase its stake in its Indian unit to 75%, from 50.7%, a deal it had announced back in September. In a statement, the company said it will offer INR3,100 a share for up to 20.6 milli
Read more
LONDON, March 10 (Reuters) - GlaxoSmithKline said on Monday it had paid 64 billion rupees ($1.05 billion) to increase its stake in its Indian pharmaceuticals unit to 75 percent, as it banks on rising demand for medicines in emerging markets. Britain's biggest drugmaker first announced plans
Read more- Asia stocks slump as Japanese, Chinese disappoint - BCC ups economic growth forecasts UK stocks will start the day in the red, dragged lower by the performance in Asia overnight, hit by both Chinese and Japanese data. City sources predict the FTSE 100 will open 21 points lower than Friday's clo
Read moreGLOBAL MARKETS ROUNDUP * Nifty futures traded on the Singapore Exchange are down 0.5 percent, while the MSCI-Asia Pacific excluding Japan index slumps 1.1 percent. * Asian stocks slipped in early trade and the dollar stepped back from its recent highs as disappointing Chinese trade data and unce
Read moreNote: Reuters has not verified this story and does not vouch for its accuracy.
Read moreLONDON (Alliance News) - GlaxoSmithKline PLC Monday said Moncef Slaoui, a divisional chairman was allocated 15 American Depositary shares under the company share plan at a price of USD55.94 per ADS Friday. Shares in the global healthcare company closed at 1,662.50 pence down 0.5% Monday.Read more
LONDON (Alliance News) - GlaxoSmithKline PLC Chief Executive Andrew Witty took a hit to his annual bonus for 2013 as a result of ongoing investigations in China, although his total pay for the year still rose 63% as the company got six products approved and five additional regulatory filings comp
Read moreLONDON (Alliance News) - GlaxoSmithKline PLC Chief Executive Andrew Witty took a hit to his annual bonus for 2013 as a result of ongoing investigations in China, although Witty's total pay for the year still rose 63% as the company saw six products approved and five additional regulatory filings
Read more
Last checked at